Year |
Citation |
Score |
2020 |
Krook MA, Lenyo A, Wilberding M, Barker H, Dantuono M, Bailey KM, Chen HZ, Reeser JW, Wing MR, Miya J, Samorodnitsky E, Smith AM, Dao T, Martin DM, Ciombor KK, et al. Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma. Molecular Cancer Therapeutics. PMID 31911531 DOI: 10.1158/1535-7163.Mct-19-0631 |
0.368 |
|
2020 |
Bonneville R, Krook MA, Chen HZ, Smith A, Samorodnitsky E, Wing MR, Reeser JW, Roychowdhury S. Detection of Microsatellite Instability Biomarkers via Next-Generation Sequencing. Methods in Molecular Biology (Clifton, N.J.). 2055: 119-132. PMID 31502149 DOI: 10.1007/978-1-4939-9773-2_5 |
0.331 |
|
2019 |
Krook MA, Bonneville R, Chen HZ, Reeser JW, Wing MR, Martin DM, Smith AM, Dao T, Samorodnitsky E, Paruchuri A, Miya J, Baker KR, Yu L, Timmers C, Dittmar K, et al. Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy. Cold Spring Harbor Molecular Case Studies. 5. PMID 31371345 DOI: 10.1101/mcs.a004002 |
0.305 |
|
2019 |
Krook MA, Barker H, Chen HZ, Reeser JW, Wing MR, Martin D, Smith AM, Dao T, Bonneville R, Samorodnitsky E, Miya J, Freud AG, Monk JP, Clinton SK, Roychowdhury S. Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 31043681 DOI: 10.1038/S41391-019-0145-2 |
0.342 |
|
2019 |
Chen HZ, Bonneville R, Yu L, Wing MR, Reeser JW, Krook MA, Miya J, Samorodnitsky E, Smith A, Martin D, Dao T, Guo Q, Liebner D, Freud AG, Allenby P, et al. Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsy. Oncotarget. 10: 277-288. PMID 30719225 DOI: 10.18632/Oncotarget.26352 |
0.386 |
|
2019 |
Chen H, Bonneville R, Krook MA, Wing MR, Reeser JW, Miya J, Paruchuri A, Samorodnitsky E, Yu L, Smith AM, Dao T, Martin D, Guo Q, Magenheim H, Freud AG, et al. Abstract 748: Genomic characterization of recurrent small cell lung cancer through research autopsy reveals clonal diversity and candidate driver of chemoresistance Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-748 |
0.31 |
|
2019 |
Krook MA, Lenyo AM, Wilberding MJ, Barker HD, Dantuono M, Chen H, Reeser JW, Wing MR, Miya J, Samorodnitsky E, Smith AM, Dao T, Martin DM, Dittmar K, Ciombor KK, et al. Abstract 335: Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma Cancer Research. 79: 335-335. DOI: 10.1158/1538-7445.Am2019-335 |
0.37 |
|
2018 |
Burkart J, Owen D, Shah MH, Abdel-Misih SRZ, Roychowdhury S, Wesolowski R, Haraldsdottir S, Reeser JW, Samorodnitsky E, Smith A, Konda B. Targeting Mutations in High-Grade Neuroendocrine Carcinoma of the Colon. Journal of the National Comprehensive Cancer Network : Jnccn. 16: 1035-1040. PMID 30181415 DOI: 10.6004/Jnccn.2018.7043 |
0.364 |
|
2017 |
Reeser JW, Martin D, Miya J, Kautto EA, Lyon E, Zhu E, Wing MR, Smith A, Reeder M, Samorodnitsky E, Parks H, Naik KR, Gozgit J, Nowacki N, Davies KD, et al. Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors. The Journal of Molecular Diagnostics : Jmd. PMID 28802831 DOI: 10.1016/J.Jmoldx.2017.05.006 |
0.385 |
|
2017 |
Datta J, Damodaran S, Parks H, Ocrainiciuc C, Miya J, Yu L, Gardner EP, Samorodnitsky E, Wing MR, Bhatt D, Hays J, Reeser JW, Roychowdhury S. Akt Activation Mediates Acquired Resistance to Fibroblast Growth Factor Receptor Inhibitor BGJ398. Molecular Cancer Therapeutics. PMID 28255027 DOI: 10.1158/1535-7163.Mct-15-1010 |
0.369 |
|
2015 |
Damodaran S, Miya J, Kautto E, Zhu E, Samorodnitsky E, Datta J, Reeser JW, Roychowdhury S. Cancer Driver Log (CanDL): Catalog of Potentially Actionable Cancer Mutations. The Journal of Molecular Diagnostics : Jmd. 17: 554-9. PMID 26320871 DOI: 10.1016/J.Jmoldx.2015.05.002 |
0.373 |
|
2015 |
Samorodnitsky E, Jewell BM, Hagopian R, Miya J, Wing MR, Lyon E, Damodaran S, Bhatt D, Reeser JW, Datta J, Roychowdhury S. Evaluation of Hybridization Capture Versus Amplicon-Based Methods for Whole-Exome Sequencing. Human Mutation. 36: 903-14. PMID 26110913 DOI: 10.1002/Humu.22825 |
0.335 |
|
2015 |
Samorodnitsky E, Datta J, Jewell BM, Hagopian R, Miya J, Wing MR, Damodaran S, Lippus JM, Reeser JW, Bhatt D, Timmers CD, Roychowdhury S. Comparison of custom capture for targeted next-generation DNA sequencing. The Journal of Molecular Diagnostics : Jmd. 17: 64-75. PMID 25528188 DOI: 10.1016/J.Jmoldx.2014.09.009 |
0.323 |
|
2014 |
Samorodnitsky E, Ghosh E. Methylation by DNMT1 is more Efficient in Chronic Lymphocytic Lymphoma Cells than in Normal Cells Journal of Proteomics & Bioinformatics. 1. DOI: 10.4172/Jpb.S10-004 |
0.326 |
|
2010 |
Samorodnitsky E, Pugh BF. Genome-wide modeling of transcription preinitiation complex disassembly mechanisms using ChIP-chip data. Plos Computational Biology. 6: e1000733. PMID 20369017 DOI: 10.1371/Journal.Pcbi.1000733 |
0.431 |
|
Show low-probability matches. |